"Management currently expects to launch FlutiCare™ in the US in the second half of 2017."
I wonder if that is considering the time it takes to get approval and manufactor the drug. I have a feeling we will be moving down for awhile unless we get great earning numbers in the meantime.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.